Cancer Science & Therapy

3^rd World Congress on Women’s Health & Breast Cancer

October 03-05, 2016 London, UK

Keynote

• Why the term of low grade ductal carcinoma in situ should be changed to Borderline Breast Disease: diagnostic and clinical implications

  Shahla Masood

  PDF HTML

• Breast reconstruction using scaffold synthetic or biological

  Pier Luigi Santi

  PDF HTML

• Targeting triple-negative breast cancer by inhibiting cancer stem-like cell (CSC) expansion

  Guan Chen

  PDF HTML

• Towards early stage detection of ovarian cancer via lysophosphatidic acid as a biomarker

  Michael Thompson

  PDF HTML

• Incidence of hyperlipidemias among premenopausal Chinese breast cancer patients after adjuvant cytotoxic chemotherapy

  Winnie Yeo

  PDF HTML